Sugi Predict

Sugi Predict / Compounds / SCHEMBL5570133

SCHEMBL5570133

SCHEMBL5570133

Cc1cc(N)ccc1Oc1cncnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.41
▸ CYP19A1 P11511 1/20 0.38
▸ PDE10A Q9Y233 1/20 0.37
▸ KDM4E B2RXH2 4/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ EGFR P00533 3/20 0.36
▸ CASP1 P29466 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ BACE1 P56817 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ERBB2 P04626 1/20 0.33
▸ ERBB3 P21860 1/20 0.33
▸ ERBB4 Q15303 1/20 0.33
▸ PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30354830 1.00 ALDH1A1 (0.41) ALDH1A1CYP19A1PDE10AKDM4ELMNA
SCHEMBL25587196 0.83 ALDH1A1 (0.41) ALDH1A1PDE10AKDM4ELMNAMAPT
SCHEMBL4798392 0.83 ALDH1A1 (0.41) ALDH1A1PDE10AKDM4ELMNAMAPT
SCHEMBL29887935 0.82 ALDH1A1 (0.53) ALDH1A1CYP19A1KDM4ELMNAMEN1
SCHEMBL1446655 0.82 ALDH1A1 (0.53) ALDH1A1CYP19A1KDM4ELMNAMEN1
SCHEMBL29764012 0.81 ALDH1A1 (0.50) ALDH1A1PDE10AKDM4ELMNAMAPT
SCHEMBL2992329 0.81 ALDH1A1 (0.52) ALDH1A1PDE10AKDM4ELMNAMAPT
SCHEMBL23850 0.81 ALDH1A1 (0.50) ALDH1A1PDE10AKDM4ELMNAMAPT
SCHEMBL24570024 0.81 VEGFA (0.41) ALDH1A1BACE1PPARGCYP3A4
SCHEMBL4696595 0.81 PPARG (0.51) KDM4EPPARGCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4169916-A1 CARBONOHYDRAZONOYL DICYANIDE COMPOUND INCLUDING AT LEAST TWO TYPES OF ARYL OR HETEROARYL LINKED BY NOVEL LINKER, AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP disclosed
WO-2021256902-A1 CARBONOHYDRAZONOYL DICYANIDE COMPOUND INCLUDING AT LEAST TWO TYPES OF ARYL OR HETEROARYL LINKED BY NOVEL LINKER, AND USE THEREOF 한국과학기술연구원 2021-12-23 — — WO disclosed
US-20070232607-A1 Quinazoline Derivatives as Erbb Receptor Tyrosine kinases BRADBURY ROBERT H 2007-10-04 — — US disclosed
EP-1756088-A1 QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES AstraZeneca AB (SE) 2007-02-28 — — EP disclosed
WO-2005118572-A1 QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES ASTRAZENECA AB (SE) 2005-12-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232607-A1 Quinazoline Derivatives as Erbb Receptor Tyrosine kinases ERBB2, ERBB3, ERBB4 ALDH1A1 3782/4885CYP19A1 801/4885PDE10A 3513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.